Revisiting cancer immunoediting by understanding cancer immune complexity

le Manjili, Masoud H
Foilsithe 2011

Tumor dormancy and relapse: from a natural by-product of evolution to a disease state

le Manjili, Masoud H.
Foilsithe in Cancer Res (2017)

The premise of personalized immunotherapy for cancer dormancy: Cancer dormancy vaccines

le Manjili, Masoud H.
Foilsithe in Oncogene (2020)

Does HER-2/neu antigen loss in metastatic breast tumors occur under immune pressure?

le Manjili, Masoud H., Kmieciak, Maciej
Foilsithe 2008

Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems

le Manjili, Masoud H., Payne, Kyle K.
Foilsithe 2012

Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs

le Manjili, Masoud H., Wang, Xiang-Yang, Abrams, Scott
Foilsithe 2014

Signatures of tumor–immune interactions as biomarkers for breast cancer prognosis

le Manjili, Masoud H, Najarian, Kayvan, Wang, Xiang-Yang
Foilsithe in Future Oncol (2012)

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma

le Gowda, Madhu, Payne, Kyle K, Godder, Kamar, Manjili, Masoud H
Foilsithe 2013

IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo

le Cha, Esther, Graham, Laura, Manjili, Masoud H., Bear, Harry D.
Foilsithe 2009

COVID-19 as an acute inflammatory disease

le Manjili, Rose H., Zarei, Melika, Habibi, Mehran, Manjili, Masoud H.
Foilsithe in J Immunol (2020)

Tumor Immunoediting and Immunosculpting Pathways to Cancer Progression

le Reiman, Jennifer M., Kmieciak, Maciej, Manjili, Masoud H., Knutson, Keith L.
Foilsithe 2007

HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses

le Kmieciak, Maciej, Knutson, Keith L., Dumur, Catherine I., Manjili, Masoud H.
Foilsithe 2007

IFN-γ Rα Is a Key Determinant of CD8+ T Cell-Mediated Tumor Elimination or Tumor Escape and Relapse in FVB Mouse

le Kmieciak, Maciej, Payne, Kyle K., Wang, Xiang-Yang, Manjili, Masoud H.
Foilsithe 2013

On the organization of human T-cell receptor loci: log-periodic distribution of T-cell receptor gene segments

le Toor, Amir A., Toor, Abdullah A., Rahmani, Mohamed, Manjili, Masoud H.
Foilsithe in J R Soc Interface (2016)

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

le Kmieciak, Maciej, Toor, Amir, Graham, Laura, Bear, Harry D., Manjili, Masoud H.
Foilsithe 2011

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk

le Payne, Kyle K., Toor, Amir A., Wang, Xiang-Yang, Manjili, Masoud H.
Foilsithe 2012

IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape and progression

le Aqbi, Hussein F., Wallace, Matthew, Sappal, Samay, Payne, Kyle K, Manjili, Masoud H
Foilsithe in J Leukoc Biol (2018)

Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine...

le Kmieciak, Maciej, Morales, Johanna K, Morales, Joshua, Bolesta, Elizabeth, Grimes, Margaret, Manjili, Masoud H.
Foilsithe 2008

GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b−Gr1− bone marrow progenitor cells into myeloid-derived suppressor cells

le Morales, Johanna K., Kmieciak, Maciej, Knutson, Keith L., Bear, Harry D., Manjili, Masoud H.
Foilsithe 2009

Tumor Escape and Progression under Immune Pressure

le Manjili, Masoud H., Egilmez, Nejat, Knutson, Keith L., Selvan, Senthamil R., Ostberg, Julie R.
Foilsithe 2012